ÀÌ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð, Á¡À¯À² ¹× ¼ºÀå ºÐ¼®(Á¦Ç° À¯Çüº°, Åõ¿© °æ·Îº°, Áõ»óº°, Á¦Çüº°, À¯Åë ä³Îº°, Áö¿ªº°) : »ê¾÷ ¿¹Ãø(2025-2032³â)
Lice Treatment Market Size, Share, and Growth Analysis, By Product Type, By Type, By Route of Administration, By Condition, By Dosage Form, By Distribution Channel, By Region - Industry Forecast 2025-2032
¼¼°èÀÇ ÀÌ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð´Â 2023³â¿¡ 22¾ï ´Þ·¯·Î Æò°¡µÇ¾ú°í, 2024³â 23¾ï 5,000¸¸ ´Þ·¯¿¡¼ 2032³â¿¡´Â 40¾ï 1,000¸¸ ´Þ·¯·Î ¼ºÀåÇϸç, ¿¹Ãø ±â°£(2025-2032³â)ÀÇ CAGRÀº 6.9%¸¦ ³ªÅ¸³¾ Àü¸ÁÀÔ´Ï´Ù.
ÀÌ Ä¡·áÁ¦ ½ÃÀåÀº À̰¡ÀÇ È®»ê·ü Áõ°¡, ½ÃÆÇ Ä¡·áÁ¦ Á¢±Ù¼º, Ä¡·á Á¦Á¦ÀÇ Çõ½ÅÀûÀÎ Áøº¸ µî ¸î °¡Áö Áß¿äÇÑ ¿äÀεé·Î ÀÎÇØ ¹ø¿µÀ» ±â´ëÇϰí ÀÖ½À´Ï´Ù. Àç´Ü°ú ÀÚ¿¬½º·´°í ¹«ÇØÇÑ Á¦Ç°¿¡ ´ëÇÑ ¼±È£µµ°¡ Áõ°¡ÇÔ¿¡ µû¶ó ¼¼°è ½ÃÀå ¼ö¿ä°¡ ´õ¿í ³ô¾ÆÁö°í ÀÖ½À´Ï´Ù. ÆíÀǼºÀÌ Á¦Ç°ÀÇ ÀÔ¼ö¼ºÀ» ³ô¿© ±â¾÷¿¡ À־ ½ÃÀå È®´ëÀÇ ±âȸ°¡ µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÈÇÐÀû Ä¡·á¿¡ ´ëÇÑ ³»¼º Áõ°¡, ÀáÀçÀû ºÎÀÛ¿ë, Àú¼Òµæ Áö¿ªÀÇ Á¦ÇÑµÈ Á¢±Ù¼º, »çȸÀû ³«ÀÎ µîÀÇ ¹®Á¦°¡ 2032³â±îÁö ½ÃÀå ħÅõ¸¦ ÀúÇØÇÒ ¼ö ÀÖ½À´Ï´Ù.
¸ñÂ÷
¼·Ð
ºÐ¼® ±â¹ý
- Á¤º¸ Á¶´Þ
- 2Â÷¡¤1Â÷ µ¥ÀÌÅÍÀÇ ¼ö¹ý
- ½ÃÀå ±Ô¸ð ¿¹Ãø
- ½ÃÀåÀÇ »óÁ¤°ú Á¦¾à
ÁÖ¿ä ¿ä¾à
- ½ÃÀå °³¿ä¿Í Àü¸Á
- ¼ö±Þ µ¿ÇâÀÇ ºÐ¼®
- ºÎ¹®º° ±âȸ ºÐ¼®
½ÃÀå ¿ªÇаú Àü¸Á
- ½ÃÀå °³¿ä
- ½ÃÀå ±Ô¸ð
- ½ÃÀå ¿ªÇÐ
- ¼ºÀå ÃËÁø¿äÀΰú ±âȸ
- ¼ºÀå ¾ïÁ¦¿äÀΰú °úÁ¦
- Porter's Five Forces ºÐ¼®
½ÃÀåÀÇ ÁÖ¿ä ÀλçÀÌÆ®
- ÁÖ¿ä ¼º°ø ¿äÀÎ
- °æÀïµµ
- ÁÖ¿ä ÅõÀÚ ±âȸ
- ½ÃÀå »ýŰè
- ½ÃÀå ¸Å·Âµµ Áö¼ö(2024³â)
- PESTEL ºÐ¼®
- °Å½Ã°æÁ¦ÁöÇ¥
- ¹ë·ùüÀÎ ºÐ¼®
- °¡°Ý ºÐ¼®
¼¼°èÀÇ ÀÌ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð¡¤CAGR : Á¦Ç° À¯Çüº°(2025-2032³â)
- ½ÃÀå °³¿ä
- ÀϹÝÀǾàǰ
- ÆÛ¸ÞÆ®¸°
- ÇÇ·¹Æ®¸°
- ±âŸ ÀϹÝÀǾàǰ
- 󹿾à
- À̹ö¸ßƾ
- ½ºÇdzë»çµå
- ¸»¶óƼ¿Â
- ±âŸ 󹿾à
¼¼°èÀÇ ÀÌ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð¡¤CAGR : À¯Çüº°(2025-2032³â)
¼¼°èÀÇ ÀÌ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð¡¤CAGR : Åõ¿© °æ·Îº°(2025-2032³â)
¼¼°èÀÇ ÀÌ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð¡¤CAGR : Áõ»óº°(2025-2032³â)
- ½ÃÀå °³¿ä
- ¸ð³¶¿°
- ÆäµðÄð·Î½Ã½º ÄÚÆÛ¸®½º
- Ä¡°ñ¿° ÆäµðÄð·Î½º
¼¼°èÀÇ ÀÌ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð¡¤CAGR : Á¦Çüº°(2025-2032³â)
- ½ÃÀå °³¿ä
- Á¤Á¦
- ¼¤Çª
- ·Î¼Ç
- Å©¸²
- ±âŸ Á¦Çü
¼¼°èÀÇ ÀÌ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð¡¤CAGR : À¯Åë ä³Îº°(2025-2032³â)
- ½ÃÀå °³¿ä
- º´¿ø ¾à±¹
- ¼Ò¸Å ¾à±¹
- ±âŸ À¯Åë ä³Î
¼¼°èÀÇ ÀÌ Ä¡·áÁ¦ ½ÃÀå ±Ô¸ð¡¤CAGR(2025-2032³â)
- ºÏ¹Ì
- À¯·´
- µ¶ÀÏ
- ½ºÆäÀÎ
- ÇÁ¶û½º
- ¿µ±¹
- ÀÌÅ»¸®¾Æ
- ±âŸ À¯·´
- ¾Æ½Ã¾ÆÅÂÆò¾ç
- Áß±¹
- Àεµ
- ÀϺ»
- Çѱ¹
- ±âŸ ¾Æ½Ã¾ÆÅÂÆò¾ç
- ¶óƾ¾Æ¸Þ¸®Ä«
- Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
- GCC ±¹°¡
- ³²¾ÆÇÁ¸®Ä«
- ±âŸ Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«
°æÀï ±¸µµ
- »óÀ§ 5°³»ç ºñ±³
- ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Æ÷Áö¼Å´×(2024³â)
- ÁÖ¿ä ±â¾÷ÀÌ Ã¤¿ëÇÑ Àü·«
- ½ÃÀåÀÇ ÃÖ±Ù µ¿Çâ
- ÁÖ¿ä ±â¾÷ÀÇ ½ÃÀå Á¡À¯À²(2024³â)
- ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
- ±â¾÷ °³¿ä
- Á¦Ç° Æ÷Æ®Æú¸®¿À ºÐ¼®
- ºÎ¹®º° Á¡À¯À² ºÐ¼®
- ¼öÀÍÀÇ Àü³â´ëºñ ºñ±³(2022-2024³â)
ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏ
- Johnson & Johnson Services, Inc.(USA)
- Reckitt Benckiser Group plc(UK)
- Perrigo Company plc(Ireland)
- Prestige Consumer Healthcare Inc.(USA)
- Sanofi SA(France)
- GlaxoSmithKline(GSK) plc(UK)
- Teva Pharmaceutical Industries Ltd.(Israel)
- Pfizer Inc.(USA)
- F. Hoffmann-La Roche Ltd.(Switzerland)
- Sun Pharmaceutical Industries Ltd.(India)
- ParaPRO LLC.(USA)
- Alliance Pharma PLC(UK)
- Arbor Pharmaceuticals, LLC.(USA)
- Oystershell Consumer Health(Belgium)
- Taro Pharmaceuticals(Canada)
- ICB PHARMA(Poland)
- Lice Clinics of America(USA)
°á·Ð°ú ±Ç°í
KTH
Global Lice Treatment Market size was valued at USD 2.2 billion in 2023 and is poised to grow from USD 2.35 billion in 2024 to USD 4.01 billion by 2032, growing at a CAGR of 6.9% during the forecast period (2025-2032).
The lice treatment market is expected to flourish due to several key factors, including the rising prevalence of lice infestations, easy access to over-the-counter treatments, and innovative advancements in treatment formulations. Government health initiatives and a growing preference for natural, non-toxic products further bolster global market demand. Increased occurrences of lice in overcrowded environments, like schools, alongside the convenience of online retail platforms, enhance product accessibility and market expansion opportunities for companies. However, challenges such as rising resistance to chemical treatments, potential side effects, limited access in low-income areas, and social stigma may hinder market penetration through 2032. Collectively, these insights highlight both the growth potential and limitations within the lice treatment sector.
Top-down and bottom-up approaches were used to estimate and validate the size of the Global Lice Treatment market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.
Global Lice Treatment Market Segments Analysis
Global Lice Treatment Market is segmented by Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel and region. Based on Product Type, the market is segmented into OTC products and Prescription medications. Based on Type, the market is segmented into Branded and Generic. Based on Route of Administration, the market is segmented into Oral and Topical. Based on Condition, the market is segmented into Pediculosis capitis, Pediculosis corporis and Pediculosis pubis. Based on Dosage Form, the market is segmented into Tablets, Shampoos, Lotions, Cream and Other dosage forms. Based on Distribution Channel, the market is segmented into Hospital pharmacies, Retail pharmacies and Other distribution channels. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.
Driver of the Global Lice Treatment Market
The Global Lice Treatment market is being propelled by innovations in treatment formulations that significantly enhance both effectiveness and user safety. Modern products, particularly those that are non-pesticide and silicone-based, effectively immobilize lice without relying on neurotoxins, thereby minimizing the risk of resistance. These advanced treatments are often odorless, cause less irritation, and require shorter application times, which ultimately improves the user experience. As a result, consumers are more likely to trust and feel satisfied with these options, leading to increased repeat purchases and positively impacting the market's growth trajectory in the coming years.
Restraints in the Global Lice Treatment Market
The global lice treatment market faces significant restraints due to the increasing resistance of lice to commonly used treatments. Chemical agents like permethrin and pyrethrin, which were once effective, have lost their potency due to overuse, resulting in treatment failures that frustrate consumers and lead to a decline in brand trust and repeat purchases. The emergence of "super lice," which are resistant to multiple chemical formulations, further complicates treatment options and underscores the need for alternative solutions. As a result, the growing demand for non-chemical treatments has contributed to a slowdown in the overall growth of the lice treatment industry.
Market Trends of the Global Lice Treatment Market
The Global Lice Treatment market is witnessing a significant trend towards preventive care, shifting from traditional reactive treatments to proactive measures. Parents and educational institutions are increasingly prioritizing strategies aimed at preventing lice infestations, resulting in heightened demand for products such as lice-repelling shampoos, sprays, and combs, especially those enriched with essential oils like rosemary and eucalyptus. This focus on prevention is not only broadening the product offering but also encouraging consumers to adopt consistent, long-term usage patterns. As awareness around lice prevention grows, the global market is expected to expand, catering to a more health-conscious demographic seeking effective solutions to combat lice infestations.
Table of Contents
Introduction
- Objectives of the Study
- Scope of the Report
- Definitions
Research Methodology
- Information Procurement
- Secondary & Primary Data Methods
- Market Size Estimation
- Market Assumptions & Limitations
Executive Summary
- Global Market Outlook
- Supply & Demand Trend Analysis
- Segmental Opportunity Analysis
Market Dynamics & Outlook
- Market Overview
- Market Size
- Market Dynamics
- Drivers & Opportunities
- Restraints & Challenges
- Porters Analysis
- Competitive rivalry
- Threat of substitute
- Bargaining power of buyers
- Threat of new entrants
- Bargaining power of suppliers
Key Market Insights
- Key Success Factors
- Degree of Competition
- Top Investment Pockets
- Market Ecosystem
- Market Attractiveness Index, 2024
- PESTEL Analysis
- Macro-Economic Indicators
- Value Chain Analysis
- Pricing Analysis
Global Lice Treatment Market Size by Product Type & CAGR (2025-2032)
- Market Overview
- OTC products
- Permethrin
- Pyrethrin
- Other OTC products
- Prescription medications
- Ivermectin
- Spinosad
- Malathion
- Other prescription medications
Global Lice Treatment Market Size by Type & CAGR (2025-2032)
- Market Overview
- Branded
- Generic
Global Lice Treatment Market Size by Route of Administration & CAGR (2025-2032)
- Market Overview
- Oral
- Topical
Global Lice Treatment Market Size by Condition & CAGR (2025-2032)
- Market Overview
- Pediculosis capitis
- Pediculosis corporis
- Pediculosis pubis
Global Lice Treatment Market Size by Dosage Form & CAGR (2025-2032)
- Market Overview
- Tablets
- Shampoos
- Lotions
- Cream
- Other dosage forms
Global Lice Treatment Market Size by Distribution Channel & CAGR (2025-2032)
- Market Overview
- Hospital pharmacies
- Retail pharmacies
- Other distribution channels
Global Lice Treatment Market Size & CAGR (2025-2032)
- North America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- Europe (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
- Asia Pacific (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
- Latin America (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- Brazil
- Rest of Latin America
- Middle East & Africa (Product Type, Type, Route of Administration, Condition, Dosage Form, Distribution Channel)
- GCC Countries
- South Africa
- Rest of Middle East & Africa
Competitive Intelligence
- Top 5 Player Comparison
- Market Positioning of Key Players, 2024
- Strategies Adopted by Key Market Players
- Recent Developments in the Market
- Company Market Share Analysis, 2024
- Company Profiles of All Key Players
- Company Details
- Product Portfolio Analysis
- Company's Segmental Share Analysis
- Revenue Y-O-Y Comparison (2022-2024)
Key Company Profiles
- Johnson & Johnson Services, Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Reckitt Benckiser Group plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Perrigo Company plc (Ireland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Prestige Consumer Healthcare Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sanofi S.A. (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- GlaxoSmithKline (GSK) plc (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Teva Pharmaceutical Industries Ltd. (Israel)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Pfizer Inc. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Sun Pharmaceutical Industries Ltd. (India)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ParaPRO LLC. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Alliance Pharma PLC (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Arbor Pharmaceuticals, LLC. (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Oystershell Consumer Health (Belgium)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Taro Pharmaceuticals (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- ICB PHARMA (Poland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
- Lice Clinics of America (USA)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Conclusion & Recommendations